Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.

Source:http://linkedlifedata.com/resource/pubmed/id/19493232

Download in:

View as

General Info

PMID
19493232